Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

TOSO Deficiency Exerts Impact On BAFF-R Expression, Thereby Causing Impaired B Cell Development in Vivo

Alexandra Schulz, PhD, Yoon Jung Park, Ph.D., Rainer Claus, MD, Hamid Kashkar, PhD, Jens Seeger, PhD, Julia Claasen, Christian P. Pallasch, MD, Christoph Plass, PhD, Michael Hallek, MD, Clemens Wendtner, Lukas P. Frenzel, MD

Blood (2012) 120 (21): 3898.

https://doi.org/10.1182/blood.V120.21.3898.3898

Published: 2012

Journal Articles

TOSO-Deficient B Cells Show An Impaired NF-κB and Migration Signaling In Vivo

Alexandra Schulz, Christian P. Pallasch, MD, Michael Hallek, MD, Lukas P. Frenzel, MD, Clemens Wendtner, MD

Blood (2011) 118 (21): 1779.

https://doi.org/10.1182/blood.V118.21.1779.1779

Published: 2011

Journal Articles

Novel X-Linked Inhibitor of Apoptosis (XIAP) Inhibiting Compound as Sensitizer for TRAIL-Mediated Apoptosis In Chronic Lymphocytic Leukemia with Poor Prognosis

Lukas P. Frenzel, MD, Michaela Patz, PhD, Christian P. Pallasch, MD, Reinhild Brinker, Julia Claasen, Alexandra Schulz, Michael Hallek, MD, Hamid Kashkar, PhD, Clemens-Martin Wendtner, MD

Blood (2010) 116 (21): 1375.

https://doi.org/10.1182/blood.V116.21.1375.1375

Published: 2010

Journal Articles

Microenvironment Influences Expression of TOSO – a Novel NF-Kappa B Target Gene In Chronic Lymphocytic Leukemia

Lukas P. Frenzel, MD, Alexandra Schulz, Christian P. Pallasch, MD, Rainer Claus, MD, Sabine Ponader, PhD, Jan A. Burger, MD, PhD, Michael Hallek, MD, Christoph Plass, PhD, Clemens-Martin Wendtner, MD

Blood (2010) 116 (21): 695.

https://doi.org/10.1182/blood.V116.21.695.695

Published: 2010

Journal Articles

Deregulation of miRNAs by Epigenetic Silencing Disrupts Suppression of the Oncogene PLAG1 in Chronic Lymphocytic Leukemia.

Christian P Pallasch, MD, Michaela Patz, PhD, Yoon Jung Park, PhD, Susanne Hagist, MD, Daniela Eggle, PhD, Rainer Claus, MD, Svenja Debey-Pascher, PhD, Alexandra Schulz, Lukas P Frenzel, MD, Julia Claasen, Nadine Kutsch, Günter Krause, PhD, Christine Mayr, MD, Andreas Rosenwald, MD, Christoph Plass, PhD, Joachim L Schultze, MD, Michael Hallek, MD, Clemens-Martin Wendtner, MD

Blood (2009) 114 (22): 3463.

https://doi.org/10.1182/blood.V114.22.3463.3463

Published: 2009

Journal Articles

miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia

Christian Philipp Pallasch, Michaela Patz, Yoon Jung Park, Susanne Hagist, Daniela Eggle, Rainer Claus, Svenja Debey-Pascher, Alexandra Schulz, Lukas P. Frenzel, Julia Claasen, Nadine Kutsch, Günter Krause, Christine Mayr, Andreas Rosenwald, Christoph Plass, Joachim L. Schultze, Michael Hallek, Clemens-Martin Wendtner

Blood (2009) 114 (15): 3255–3264.

https://doi.org/10.1182/blood-2009-06-229898

Published: 2009

Includes: Supplemental data

Journal Articles

Overexpression of TOSO in CLL Is Triggered by B-Cell Receptor Signaling and Associated with Progressive Disease.

Christian P Pallasch, MD, Alexandra Schulz, Nadine Kutsch, Janine Schwamb, Susanne Hagist, MD, Claudia Wickenhauser, MD, Alfred Ultsch, PhD, Hamid Kashkar, PhD, Michael Hallek, MD, Clemens-Martin Wendtner, MD

Blood (2008) 112 (11): 2070.

https://doi.org/10.1182/blood.V112.11.2070.2070

Published: 2008

Journal Articles

Deregulation of Micrornas Results in Overexpression of Oncogenic Transcription Factors Involved in Pathogenesis of CLL.

Christian P Pallasch, MD, Susanne Hagist, MD, Michaela Patz, Alexandra Schulz, Svenja Debey, Daniela Eggle, Joachim L Schultze, MD, Michael Hallek, MD, Clemens-Martin Wendtner, MD

Blood (2008) 112 (11): 2075.

https://doi.org/10.1182/blood.V112.11.2075.2075

Published: 2008

Journal Articles

Overexpression of TOSO in CLL is triggered by B-cell receptor signaling and associated with progressive disease

Christian Philipp Pallasch, Alexandra Schulz, Nadine Kutsch, Janine Schwamb, Susanne Hagist, Hamid Kashkar, Alfred Ultsch, Claudia Wickenhauser, Michael Hallek, Clemens-Martin Wendtner

Blood (2008) 112 (10): 4213–4219.

https://doi.org/10.1182/blood-2008-05-157255

Published: 2008

Includes: Supplemental data

Journal Articles

Overexpression of Lipases Enables Specific Cytotoxicity by the Lipase Inhibitor Orlistat in Chronic Lymphocytic Leukemia Cells.

Christian P. Pallasch, MD, Janine Schwamb, Alexandra Schulz, Svenja Debey, PhD, David Kofler, MD, Joachim L. Schultze, MD, Michael Hallek, MD, Alfred Ultsch, PhD, Clemens M. Wendtner, MD

Blood (2006) 108 (11): 2800.

https://doi.org/10.1182/blood.V108.11.2800.2800

Published: 2006

NARROW

TOSO Deficiency Exerts Impact On BAFF-R Expression, Thereby Causing Impaired B Cell Development in Vivo

TOSO-Deficient B Cells Show An Impaired NF-κB and Migration Signaling In Vivo

Novel X-Linked Inhibitor of Apoptosis (XIAP) Inhibiting Compound as Sensitizer for TRAIL-Mediated Apoptosis In Chronic Lymphocytic Leukemia with Poor Prognosis

Microenvironment Influences Expression of TOSO – a Novel NF-Kappa B Target Gene In Chronic Lymphocytic Leukemia

Deregulation of miRNAs by Epigenetic Silencing Disrupts Suppression of the Oncogene PLAG1 in Chronic Lymphocytic Leukemia.

miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia

Overexpression of TOSO in CLL Is Triggered by B-Cell Receptor Signaling and Associated with Progressive Disease.

Deregulation of Micrornas Results in Overexpression of Oncogenic Transcription Factors Involved in Pathogenesis of CLL.

Overexpression of TOSO in CLL is triggered by B-cell receptor signaling and associated with progressive disease

Overexpression of Lipases Enables Specific Cytotoxicity by the Lipase Inhibitor Orlistat in Chronic Lymphocytic Leukemia Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only